cell-free DNA South Korean Firm EDGC to Expand Reach Into Liquid Biopsy Space With Cell-Free DNA Platform Premium The firm expects to replace its current screening assay with the methylation test following regulatory clearance from the country's Ministry of Food and Drug Safety. BillionToOne Raises $55M in Series B Financing The firm said the funding will help it pay for a recent laboratory expansion, growth of its commercial team, and new product development in the oncology space. Tool Detects Pediatric Bone Tumors From Liquid Biopsies Based on Epigenetic Profiles Epigenetic signatures of Ewing sarcoma affect cell-free DNA fragmentation patterns and can be used to detect cancer. Freenome Eyes New Dx Possibilities for Core Technology as CRC Detection Trial Progresses Premium The firm continues to pursue new applications for its multiomics machine learning technology, with recent data exploring immunotherapy response prediction. Arcedi Biotech Introduces NIPT Analyzing DNA From Rare Fetal Cells in Maternal Blood Premium The company is positioning the blood-based test as an alternative to invasive chorionic villus sampling, the current standard in Denmark. Apr 7, 2021 OncoDNA, myNEO Partner to Advance Bespoke mRNA-Based Cancer Vaccines Apr 6, 2021 Scottish Liquid Biopsy Startup BioCaptiva Raises £1M in Seed Funding Mar 31, 2021 Delfi Diagnostics Starts Prospective Lung Cancer Screening Trial Mar 25, 2021 Quantgene, CureMatch Partner to Guide Precision Cancer Treatment Mar 16, 2021 NephroSant Raises $16M in Series A Funding Round Mar 2, 2021 Twist Bioscience, Watchmaker Genomics Partner on High-Throughput NGS Applications Mar 1, 2021 TGen-Led Team Spots Pediatric, Pancreatic Cancer From cfDNA Fragments in Urine Premium Feb 26, 2021 Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium Jan 11, 2021 Resolution Bioscience, Mirati Therapeutics Sign Companion Diagnostic Agreement Dec 4, 2020 Ravgen Sues Illumina, Roche Alleging Infringement of Cell-Free DNA Testing Patents Dec 2, 2020 Judge Denies Natera Motion to Invalidate CareDx, Stanford Patents Nov 20, 2020 Agena Bioscience Shows Off New Liquid Biopsy QC Assay at AMP; Expects January Launch Premium Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Nov 2, 2020 Researchers Turn Methylated DNA Profiling Method Towards Prenatal Testing Applications Premium Oct 22, 2020 Summit Biolabs Commercializing Tests for Head and Neck Cancer Recurrence, COVID-19 Premium Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 20, 2020 Sophia Genetics Using $110M Funding Round to Focus on New Markets, Continued Collaboration Premium Oct 7, 2020 Prenatal Diagnosis Society Recommends cfDNA Screening for Autosomal Trisomies in Twin Pregnancies Oct 2, 2020 Natera Molecular Residual Disease Test to be Used in Breast Cancer Trial of Ibrance Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.